117 - Mesenchymal Stem/Stromal Cells: INTERIM REPORT FROM THE NEPHSTROM MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-1B CLINICAL TRIAL OF A NOVEL MESENCHYMAL STROMAL CELL THERAPY IN PROGRESSIVE DIABETIC KIDNEY DISEASE

Autor: Griffin, M., Perico, N., Cockwell, P., Maxwell, P., Rubis, N., Casiraghi, F., Villa, A., Ruggenenti, P., Cappelletti, L., McInerney, V., Duffy, A., Finnerty, A., Smythe, J., Pedrini, O., Golay, J., Introna, M., Steeneveld, E., Roelofs, H., Fibbe, W., Elliman, S.J., Remuzzi, G., O’Brien, T.
Zdroj: In Cytotherapy May 2022 24(5) Supplement:S50-S51
Databáze: ScienceDirect